Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus

Published:2023-02 Issue: Volume:110 Page:154634
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Zhou Duanfang,Li Xiaoli,Xiao Xiaoqiu,Wang Gang,Chen Bo,Song Yi,Liu Xu,He Qichen,Zhang Huan,Wu Qiuya,Zhang Limei,Wu Lihong,Shen Zhengze,Hassan Moustapha,Zhao Ying,Zhou Weiying^ORCID

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference52 articles.

1. Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway;Amin;Life Sci.,2020

2. TXNIP positively regulates the autophagy and apoptosis in the rat müller cell of diabetic retinopathy;Ao;Life Sci.,2021

3. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes;Chen;Faseb J.,2008

4. Thioredoxin-interacting protein stimulates its own expression via a positive feedback loop;Chen;Mol. Endocrinol.,2014

5. Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3;Chen;Biochim. Biophys. Acta,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases;Redox Biology;2024-04

2. Celastrol as an intestinal FXR inhibitor triggers tripolide-induced intestinal bleeding: Underlying mechanism of gastrointestinal injury induced by Tripterygium wilfordii;Phytomedicine;2023-12

3. Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development;Pharmacological Research;2023-10

4. pH-Activatable Charge-Reversal Polymer-Based Nanocarriers for Targeted Delivery of Antihepatoma Compound;Langmuir;2023-09-13

5. N76-1, a novel CDK7 inhibitor, exhibits potent anti-cancer effects in triple negative breast cancer;European Journal of Pharmacology;2023-09